The Notification Letter is only a notification of deficiency and has no immediate effect on the listing or trading of the Shares and the Shares will continue to trade on Nasdaq under the symbol “ORIO.
Kirby McInerney LLP reminds investors who purchased ADMA Biologics, Inc. (“ADMA” or the “Company”) (NASDAQ:ADMA) securities to contact Lauren Molinaro of Kirby ...
On March 17, 2026, MyCard, Inc. (d/b/a Knot) filed a bombshell complaint in the District of Delaware, alleging that it had caught Atomic FI, ...
Military veterans reported fewer flashbacks and nightmares related to PTSD after spending a 60-minute session in a ...